Visual screening and efficacy evaluation of high-performance fluorescent probe DAF-FM in esophagitis cancer transformation

Figure 1 Imaging of a rat model of esophagitis. A: Hematoxylin-eosin staining of esophageal tissue in the normal control group (left) and esophagitis model group (right); B: Quantitative statistical chart of inflammatory cell count per field of view (normal group: 8.2 ± 1.5, esophagitis group: 35.6 ± 4.2); C: Quantitative statistical chart of epithelial defect area (normal group: 0 mm², esophagitis group: 0.12 ± 0.03 mm²); D: Quantitative statistical chart of submucosal edema thickness (normal group: 0.02 ± 0.01 mm, esophagitis group: 0.08 ± 0.02 mm); E: Quantitative statistical chart of ulcer number per rat (normal group: 0, esophagitis group: 2.3 ± 0.5). Scale bar: 250 μm; data are expressed as mean ± SD, n = 10 per group, ^bP < 0.01.